Melinta Therapeutics (formerly Rib-X Pharmaceuticals)
CEO:
Mary Szela
Year Established:
2000
About:
Melinta Therapeutics is an antibiotics company engaged in the discovery, development and commercialization of antibiotics to overcome drug-resistant, life-threatening infections. Melinta was formerly known as Rib-X Pharmaceuticals, and changed its name to Melinta Therapeutics on October 7, 2013.
Website:
www.melinta.com
CI Representative:
Daniel Wagner
Managing Director, Investments
